We are live on ! Find out more
MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$21.6M
Cap. Flow
-$43.9M
Cap. Flow %
-17.47%
Top 10 Hldgs %
56.38%
Holding
35
New
4
Increased
11
Reduced
10
Closed
10

Top Buys

Rank Stock Value
1
SEM
Select Medical
SEM
+$10M
2
ENZY
Enzymotec Ltd
ENZY
+$6.63M
3
AEGR
Aegerion Pharmaceuticals
AEGR
+$6.33M
4
WST icon
West Pharmaceutical
WST
+$5.36M
5
RMD icon
ResMed
RMD
+$4.45M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$13.9M
2
MDT icon
Medtronic
MDT
+$11.2M
3
ARAY icon
Accuray
ARAY
+$9.7M
4
MGLN
Magellan Health Services, Inc.
MGLN
+$7.92M
5
ITMN
INTERMUNE INC
ITMN
+$7.75M

Sector Composition

Rank Sector Weight
1 Healthcare 94.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$26.2B
$21.8M 8.68%
169,552
-74,521
-31% -$7.68M
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$17.7M 7.04%
196,176
-8,706
-4% -$681K
DXCM icon
3
DexCom
DXCM
$28.8B
$15.4M 6.12%
1,538,212
-50,848
-3% -$520K
AEGR
4
DELISTED
Aegerion Pharmaceuticals
AEGR
$13.5M 5.35%
403,054
+204,017
+103% +$6.33M
LLY icon
5
Eli Lilly
LLY
$1.03T
$13.1M 5.2%
201,448
-109,469
-35% -$6.93M
JNJ icon
6
Johnson & Johnson
JNJ
$617B
$13M 5.19%
122,361
+19,593
+19% +$2.03M
EHC icon
7
Encompass Health
EHC
$11B
$13M 5.18%
443,274
+143,657
+48% +$4.38M
ZLTQ
8
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$12.2M 4.85%
538,390
-89,133
-14% -$1.76M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$11.1M 4.43%
67,080
-2,169
-3% -$356K
BIIB icon
10
Biogen
BIIB
$30.7B
$10.9M 4.34%
32,986
+7,825
+31% +$2.58M
AMAG
11
DELISTED
AMAG Pharmaceuticals
AMAG
$10.8M 4.3%
338,723
+192,305
+131% +$4.1M
ZTS icon
12
Zoetis
ZTS
$31.9B
$10.7M 4.27%
290,514
+117,480
+68% +$4.02M
ACOR
13
DELISTED
Acorda Therapeutics
ACOR
$10.3M 4.09%
2,529
+556
+28% +$2.09M
HCA icon
14
HCA Healthcare
HCA
$85.7B
$10.2M 4.06%
144,586
-60,469
-29% -$4M
PRGO icon
15
Perrigo
PRGO
$1.43B
$10.1M 4.01%
67,052
+11,498
+21% +$1.71M
COR icon
16
Cencora
COR
$60.7B
$9.88M 3.93%
127,799
-63,871
-33% -$4.86M
UHS icon
17
Universal Health Services
UHS
$9.88B
$9.7M 3.86%
92,807
-19,080
-17% -$2.03M
UAM
18
DELISTED
Universal American Corp
UAM
$9.08M 3.61%
1,129,028
+443,028
+65% +$3.66M
SEM
19
DELISTED
Select Medical
SEM
$8.4M 3.34%
+1,295,778
New +$10M
WST icon
20
West Pharmaceutical
WST
$23.9B
$6.21M 2.47%
138,798
+126,167
+999% +$5.36M
ENZY
21
DELISTED
Enzymotec Ltd
ENZY
$4.55M 1.81%
681,778
+614,315
+911% +$6.63M
RMD icon
22
ResMed
RMD
$30.3B
$4.3M 1.71%
+87,335
New +$4.45M
UAM
23
CALL
DELISTED
Universal American Corp
UAM
$4.02M 1.6%
+500,000
New +$4.13M
MNTA
24
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.18M 0.47%
+103,729
New +$1.18M
LMNX
25
DELISTED
Luminex Corp
LMNX
$195K 0.08%
10,000
-134,274
-93% -$2.45M
1
2

Similar funds

IC
IKOS CIF Limassol, Cyprus $16.7M AUM 0.4% 1-Year Est. Return
PA
Para Advisors New York $17.5M AUM 3.99% 1-Year Est. Return
GMIM
General Motors Investment Management New York $20.3M AUM 55.51% 1-Year Est. Return
JHWCP
J.H. Whitney Capital Partners New Canaan, Connecticut $11.5M AUM 86.36% 1-Year Est. Return
SMPIAI
Spark Management Partners III (AIV I) Boston, Massachusetts $10.1M AUM 12.29% 1-Year Est. Return
NCMG
NCM Capital Management Group Durham, North Carolina $8.24M AUM 11.99% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

March Altus Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, March Altus Capital Management held 35 positions worth $251M, down 7.9% from $273M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

March Altus Capital Management withdrew a net $43.9M in Q3 2014, closing 10 positions and reducing 10 holdings. Its most notable exit was AbbVie, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 92% a quarter earlier.

Against the trend, March Altus Capital Management opened a new position in Select Medical worth $8.4M.

  • March Altus Capital Management's largest Q3 2014 buy was Select Medical: 1,295,778 shares worth $8.4M.
  • March Altus Capital Management added most to Enzymotec Ltd in Q3 2014, an estimated $6.63M increase.
  • March Altus Capital Management's biggest Q3 2014 reduction was United Therapeutics, cutting an estimated $7.68M.
  • March Altus Capital Management fully exited AbbVie in Q3 2014, selling an estimated $13.9M.
  • March Altus Capital Management's ten largest holdings make up 56% of its $251M portfolio in Q3 2014.
  • March Altus Capital Management opened 4 new positions and closed 10 in Q3 2014.
  • March Altus Capital Management's portfolio value fell 7.9% quarter-over-quarter to $251M.

Based on March Altus Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.